Clearpoint neuro, inc. (MRIC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenues:
Service revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

142

108

-

-

-

-

Product revenues

-

-

-

-

-

-

-

-

-

-

-

-

1,922

1,586

1,580

1,066

1,366

1,455

1,209

774

976

922

588

1,154

713

1,107

850

497

460

339

318

291

221

450

504

72

126

Development service revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

22

-

0

0

4

98

15

49

65

153

-

163

-

-

-

-

-

-

Service and other revenues

-

-

-

-

-

-

-

-

-

-

-

-

84

48

35

37

27

44

33

29

33

37

44

29

10

-

28

-

-

-

-

-

-

-

-

-

-

Related party license revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

650

1,396

650

650

650

650

650

650

650

Total revenues

3,115

3,210

2,927

2,606

2,472

2,276

1,807

1,646

1,623

1,679

1,717

1,976

2,007

1,635

1,616

1,103

1,394

1,511

1,246

825

1,010

959

633

1,188

822

1,176

927

562

1,264

1,862

1,131

1,083

979

1,164

1,154

722

776

Cost of revenues

917

933

983

1,030

886

688

553

602

588

-

688

798

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenues

-

-

-

-

-

-

-

-

-

-

-

-

752

676

748

520

696

646

560

394

385

683

315

576

350

533

365

295

226

163

133

156

101

235

308

30

82

Research and development costs

829

878

761

697

584

481

617

665

546

582

589

1,084

557

529

691

749

657

522

480

426

527

707

873

898

817

684

725

741

771

735

573

486

689

1,117

909

1,058

1,165

Sales and marketing expenses

1,298

1,508

1,063

1,143

1,040

878

764

926

962

1,011

899

979

1,066

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reversal of research and development obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

882

-

-

-

-

-

General and administrative expenses

1,278

1,308

1,029

1,028

933

1,206

1,078

1,088

952

1,259

866

935

984

-1,558

1,886

1,888

1,974

1,761

2,132

2,187

2,288

2,247

2,062

1,929

1,800

2,026

1,697

1,703

1,633

1,444

1,441

1,803

1,340

1,122

1,367

1,105

1,235

Restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

499

753

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,338

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,343

2,148

1,563

2,131

2,475

2,585

2,194

2,483

Operating loss

-1,208

-1,417

-910

-1,293

-972

-978

-1,206

-1,635

-1,427

-1,832

-1,327

-1,822

-1,353

-1,790

-1,709

-2,055

-1,933

-1,419

-1,927

-2,682

-2,944

-2,678

-2,618

-2,215

2,192

-2,068

-1,861

-2,178

-1,367

-481

-1,017

-479

-1,151

-1,311

-1,430

-1,472

-1,707

Other income (expense):
Gain on change in fair value of derivative liabilities

-

-

-

-

-

0

22

7

34

-23

109

31

-93

317

324

263

160

558

1,950

-186

-782

971

-781

875

483

358

-1,250

955

1,623

-

-1,667

-

-

-

-

-

-

Loss on debt restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-933

121

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on forgiveness of amounts in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-

-

Loss on note payable modification

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,356

-

-

-

-

-

-

-

-

Other income (expense), net

-33

1

0

1

5

-1

2

-0

-0

9

3

-0

4

6

-4

139

75

-12

45

115

82

7

38

25

103

-350

39

-6

374

-

2

-25

-

107

0

-0

-2

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

2

4

7

1

2

4

2

3

5

7

7

3

7

1

1

0

0

1

1

Interest expense, net

813

228

213

259

254

237

246

248

247

235

211

212

213

215

239

251

345

326

316

311

307

294

288

283

151

136

127

129

105

87

85

96

2,325

652

705

598

541

Net loss

-2,054

-1,645

-1,122

-1,550

-1,220

-1,217

-1,428

-1,876

-1,640

-2,081

-1,425

-2,004

-1,655

-1,680

-2,563

-1,781

-2,043

-1,198

-245

-3,060

-3,945

-1,914

-3,647

-1,593

2,630

-1,715

-3,194

-1,351

-823

957

-2,761

-599

-3,474

-1,855

-2,135

-2,069

-2,250

Net loss per share attributable to common stockholders:
Basic and diluted (in dollars per share)

-0.13

-0.10

-0.08

-0.13

-0.11

-0.11

-0.13

-0.17

-0.15

-0.01

-0.14

-0.32

-0.46

-0.22

-0.92

-0.90

-0.89

-2.66

-0.13

-1.64

-0.05

-

0.00

-

-

-

-0.05

-

-

0.06

-0.06

-0.01

-0.14

-0.12

-0.13

-0.13

-0.14

Weighted average shares outstanding:
Basic and diluted (in shares)

15,438

15,220

14,053

12,302

11,044

11,004

11,006

10,959

10,741

10,676

10,339

6,315

3,622

3,977

2,779

1,971

2,291

-71,047

1,872

1,871

74,842

-

58,957

-

-

-

58,254

-

-

48,181

47,531

40,596

25,187

16,084

16,041

15,859

15,859

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

0.04

-

-

-0.02

-0.02

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

0.04

-

-

-0.02

-0.02

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58,919

58,716

-

-

57,384

54,860

-

-

-

-

-

-

-

-

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58,919

61,248

-

-

57,384

54,860

-

-

-

-

-

-

-

-

Product Revenue
Total revenues

2,103

2,523

2,594

2,194

2,163

1,994

1,739

1,412

1,538

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Service and Other Revenues
Total revenues

1,012

686

333

412

308

282

67

233

84

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-